SG Americas Securities’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182K Buy
119,098
+69,500
+140% +$106K ﹤0.01% 2840
2026
Q1
$90K Buy
+49,598
New +$85.8K ﹤0.01% 2958
2025
Q3
Sell
-12,538
Closed -$12K 3505
2025
Q2
$12K Sell
12,538
-88,171
-88% -$73.1K ﹤0.01% 2853
2025
Q1
$71K Sell
100,709
-51,467
-34% -$35.6K ﹤0.01% 3154
2024
Q4
$123K Buy
152,176
+64,080
+73% +$58.7K ﹤0.01% 2580
2024
Q3
$87K Buy
+88,096
New +$121K ﹤0.01% 3118
2023
Q2
Sell
-87,245
Closed -$74K 2909
2023
Q1
$74K Buy
87,245
+77,110
+761% +$84.1K ﹤0.01% 2996
2022
Q4
$13K Sell
10,135
-34,099
-77% -$53.1K ﹤0.01% 2960
2022
Q3
$79K Sell
44,234
-200,762
-82% -$500K ﹤0.01% 2912
2022
Q2
$556K Buy
244,996
+157,573
+180% +$377K 0.01% 1874
2022
Q1
$288K Buy
87,423
+65,811
+305% +$231K ﹤0.01% 2220
2021
Q4
$98K Sell
21,612
-48,689
-69% -$368K ﹤0.01% 3093
2021
Q3
$505K Buy
+70,301
New +$516K ﹤0.01% 2498

Other funds holding OCGN

SG Americas Securities's OCGN Position: Q2 2026 in Review

SG Americas Securities increased its Ocugen (OCGN) stake by 140% in Q2 2026, buying an estimated $106K and bringing the position to 119,098 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2840.

SG Americas Securities first reported a position in OCGN in Q3 2021 and has held it in 13 quarters since. The position peaked at $556K in Q2 2022. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • SG Americas Securities held 119,098 shares of Ocugen worth $182K as of Q2 2026.
  • SG Americas Securities bought 69,500 Ocugen shares in Q2 2026, an estimated $106K.
  • Ocugen made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2840 holding.
  • SG Americas Securities first reported a position in Ocugen in Q3 2021 and has held it in 13 quarters since.
  • SG Americas Securities's Ocugen position peaked at $556K in Q2 2022.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.